US Patent 11926592 Salts and crystal forms of omecamtiv mecarbil

Is a

Patent

Patent attributes

Patent Applicant

Amgen

Current Assignee

Amgen

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

119265920

Patent Inventor Names

Ron C. Kelly0

Sebastien Caille0

Bin Peter Quan0

Jaclyn Raeburn0

Henry Morrison0

Lingyun Xiao0

David Pearson0

Sheng Cui0

...

Date of Patent

March 12, 2024

Patent Application Number

179296450

Date Filed

September 2, 2022

Patent Citations

‌

US Patent 8445495 Certain Chemical entities, compositions and methods

‌

US Patent 7507735 Compounds, compositions and methods

‌

US Patent 8101617 Disubstituted ureas and uses thereof in treating heart failure

‌

US Patent 8110595 Ureas and their use in the treatment of heart failure

‌

US Patent 9643925 Compounds, compositions and methods

‌

US Patent 9895308 Heterocyclic compounds and their uses

‌

US Patent 9951015 Heterocyclic compounds and their uses

‌

US Patent 9988354 Salt of omecamtiv mecarbil and process for preparing salt

...

Patent Primary Examiner

CPC Code

Patent abstract

Provided herein are free base crystalline forms, crystalline salts, and an amorphous salts of omecamtiv mecarbil.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

US Patent 11926592 Salts and crystal forms of omecamtiv mecarbil

Contents

Patent attributes

Timeline

Further Resources

References

Find more entities like US Patent 11926592 Salts and crystal forms of omecamtiv mecarbil